Marble Bar Asset Management LLP

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1346570 LONDON, X0

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$335,130

New position

Shares Held

3,537

first reported quarter

Ownership

0.024%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#104

of 161 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Marble Bar Asset Management LLP holds $3,140,384 across 4 Biotechnology names. INBX ranks #3 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RNA	Atrium Therapeutics, Inc.	103,849	$1,396,769
2	OCUL	Ocular Therapeutix, Inc	122,518	$1,203,126
3	INBX	Inhibrx Biosciences, Inc. This page	3,537	$335,130
4	OCS	Oculis Holding AG	14,806	$205,359

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$335,130	3,537	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.